Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients

被引:35
作者
Dummer, R
Mittelman, A
Fanizzi, FP
Lucchese, G
Willers, J
Kanduc, D
机构
[1] Univ Bari, Dept Biochem & Mol Biol, I-70125 Bari, Italy
[2] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[3] New York Med Coll, Dept Med Oncol, Valhalla, NY 10595 USA
[4] CARSO, Ctr Canc Res, NMR Unit, Valenzano, Italy
关键词
melanoma; antigenic epitope; immunogenic peptide; antoantibody; non-self-discrimination;
D O I
10.1002/ijc.20310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analyzed the sera of patients with melanoma to define the human humoral autoantibody profile towards HMW-MAA. Computational proteome scanning using the non-self-discrimination principle as a guide led to the individuation of the low-similarity HMW-MAA(781-789)RATVWMLRL peptide fragment as an immunodominant B-cell epitope. Linear B-cell determinant individuation was experimentally validated by dot blot immunoassay and NMR spectroscopy analysis. Regulation of physiologic self-reactivity by the non-self-discrimination principle is discussed. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 38 条
  • [1] BERZOFSKY JA, 1993, ANN NY ACAD SCI, V690, P256
  • [2] Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients
    Bosscher, JR
    Gercel-Taylor, C
    Watkins, CS
    Taylor, DD
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 81 (02) : 138 - 143
  • [3] Coupling and uncoupling of tumor immunity and autoimmunity
    Bowne, WB
    Srinivasan, R
    Wolchok, JD
    Hawkins, WG
    Blachere, NE
    Dyall, R
    Lewis, JJ
    Houghton, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) : 1717 - 1722
  • [4] Cohn M, 1990, IMMUNOL REV, V115, P1
  • [5] Desai SA, 1998, CANCER RES, V58, P2417
  • [6] HUMAN HIGH-MOLECULAR-WEIGHT MELANOMA-ASSOCIATED ANTIGEN MIMICRY BY MOUSE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES MK2-23 - EXPERIMENTAL STUDIES AND CLINICAL-TRIALS IN PATIENTS WITH MALIGNANT-MELANOMA
    FERRONE, S
    CHEN, ZJ
    LIU, CC
    HIRAI, S
    KAGESHITA, T
    MITTELMAN, A
    [J]. PHARMACOLOGY & THERAPEUTICS, 1993, 57 (2-3) : 259 - 290
  • [7] FERRONE S, 1995, BIOL THERAPY CANC, P77
  • [8] Ferrone Soldano, 1993, Journal of Dermatology (Tokyo), V20, P533
  • [9] Fishman P, 1997, CANCER, V79, P1461, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO
  • [10] 2-E